Recent Articles
GLP-1 Drugs, Psilocybin Mushrooms, and the Case for Sublingual Psilocin
More people than ever are taking GLP-1 receptor agonists—drugs like Ozempic (semaglutide), Wegovy, and Mounjaro. These medications, originally developed for type 2 diabetes, are now widely prescribed for weight loss. They work by mimicking the body’s natural GLP-1 hormone, which regulates blood sugar, slows stomach emptying, suppresses appetite, and alters gut motility. This creates a […]
By Joe Moore
Psilocybin Enters German Psychiatry: A Clinical Milestone for Mental Health
By Joe Moore
Filter
When it Comes to Psychedelic Access, It’s the Messenger, Not the Message
By Robert Johnson No one in the 21st-century psychedelic pantheon has crossed over to the…
By Robert Johnson
Accredited Entheogenic Seminary: Inside the Congregation for Sacred Practices with Paul Ryder
Last week, Investigative Reporter and Psychedelic State(s) of America founder Jack Gorsline sat down with…
By Jack Gorsline
Does Cannabis Research Deserve As Much Funding As Ibogaine Research?
While waves of change diffused across psychedelic science and research policy in Texas, bills such…
By Halle Tarvin, MA, MS
Win 10 Groundbreaking Psychedelic Books – Our Giveaway with Inner Traditions!
We’re thrilled to partner with Inner Traditions, one of the world’s most respected publishers of…
Statement Regarding The Church of the Sacred Synthesis
In the last few weeks, Psychedelics Today has been in conversation with leadership at the…
By Joe Moore
Reflections on the 2025 Federal Summit on Psychedelic Medicine
By Joe Moore A Historic Gathering in Washington On May 8, the Psychedelic Medicine Coalition…